$CPIX Cashflow Statement | Understand Stock

$CPIX

$4.87 -$0.08 (1.62%) Close

$CPIX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Discontinued operations net of tax
Net income (loss) from continuing operations
Adjustments to reconcile net loss to net cash flows provided by (used in) operating activities:
Depreciation and amortization expense
Deferred tax expense
Impairment loss on intangible assets
Amortization of operating lease right-of-use asset
Loss on co-commercialization investment
Disposal of assets
Stock-based compensation
Decrease in non-cash contingent consideration
Write off of deferred offering costs
Increase (decrease) in non-cash contingent consideration
Increase in cash surrender value of life insurance policies over premiums paid
Noncash interest expense
Noncash gain on RediTrex transaction
Life insurance proceeds
Gain on forgiveness of debt
Net changes in assets and liabilities affecting operating activities:
Accounts receivable
Inventories, net
Other current assets and other assets
Operating lease liabilities
Accounts payable and other current liabilities
Other long-term liabilities
Net cash provided by operating activities from continuing operations

Net cash provided by (used in) operating activities

Cash flows from investing activities:
Additions to property and equipment
Additions to intangible assets
Proceeds from surrender of life insurance policies
Premiums paid for life insurance policies
Return of RediTrex
Net investment in manufacturing
Note receivable investment funding
Proceeds from sale of marketable securities
Purchases of marketable securities
Other investment
Increase in cash surrender value of life insurance policies
Life insurance policy proceeds received
Settlement of patent litigation
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Borrowings on line of credit
Payments on line of credit
Proceeds from ATM offering, net
Payments made in connection with repurchase of common shares
Cash settlement of contingent consideration
Payments for Repurchase of Redeemable Noncontrolling Interest
Proceeds from Noncontrolling Interests
Payments of deferred equity offering costs
Payments of Financing Costs
Net cash provided by (used in) financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

Supplemental disclosure of cash flow information:
Net cash paid during the year for:
Interest
State income taxes
Total cash paid included in measurement of lease liability
Noncash investing and financing activities:
Change in unpaid invoices for intangible asset additions
Deferred offering costs included in accounts payable and other accrued expenses
Change in unpaid invoices for offering costs
Lease liability obtained from right-of-use assets
Vesting of shares related to RediTrex approval
Repurchase of subsidiary shares from noncontrolling interests
Additions to intangible assets from final purchase price allocation
RediTrex forgiveness of milestone payable
Return of shares related to RediTrex
Other investment liability

Comments